90 results
Page 4 of 5
DEFA14A
EX-4.3
zdoon1i7n frsgv2hn
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.2
b2l3j x5n
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
1i3t3k
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.1
r28004w5a7jlct urd
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.3
77p995wl
6 Apr 10
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-4.2
1dlkq84 3oyyll
6 Apr 10
Additional proxy soliciting materials
12:00am
8-K
EX-4.1
s68dbrzavcgqdep
5 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
ctrmt2p9zvdp4oxoyh
14 Jan 10
MDRNA, Inc. Raises $5.5 Million in Registered Direct Offering
12:00am
8-K
EX-4.2
4lcysv9
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.1
u9f0x lbtgyj
24 Dec 09
MDRNA, Inc. Announces Closing of $1 Million Bridge Loan
12:00am
8-K
EX-4.1
l6geryj 9uspvwssve
19 Jan 07
Entry into a Material Definitive Agreement
12:00am
S-8
EX-4.5
3y8i041 0du3h
10 Jul 02
Registration of securities for employees
12:00am
8-K
EX-4.2
ahg2ulmv
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am
8-K
EX-4.1
g40w52dh3 x2mx7g
20 Feb 02
Nastech and Pharmacia Reach Worldwide Agreement to Develop and Market Nasally Administered Apomorphine
12:00am